ANI Pharmaceuticals Inc’s recent filing unveils that its Director Walsh Patrick D unloaded Company’s shares for reported $0.75 million on Nov 13 ’25. In the deal valued at $86.88 per share,8,643 shares were sold. As a result of this transaction, Walsh Patrick D now holds 61,405 shares worth roughly $5.03 million.
Then, Gassert Chad sold 14,642 shares, generating $1,304,163 in total proceeds. Upon selling the shares at $89.07, the SVP – CORP. DEV. & STRATEGY now owns 158,584 shares.
Before that, Gassert Chad sold 94 shares. ANI Pharmaceuticals Inc shares valued at $8,272 were divested by the SVP – CORP. DEV. & STRATEGY at a price of $88.00 per share. As a result of the transaction, Gassert Chad now holds 158,490 shares, worth roughly $12.99 million.
H.C. Wainwright initiated its ANI Pharmaceuticals Inc [ANIP] rating to a Buy in a research note published on July 10, 2025; the price target was $84. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. JP Morgan began covering ANIP with “an Overweight” recommendation on March 12, 2025. Leerink Partners started covering the stock on December 11, 2024. It rated ANIP as “an Outperform”.
Price Performance Review of ANIP
On Monday, ANI Pharmaceuticals Inc [NASDAQ:ANIP] saw its stock fall -2.44% to $81.97. Over the last five days, the stock has lost -7.83%. ANI Pharmaceuticals Inc shares have risen nearly 37.00% since the year began. Nevertheless, the stocks have risen 48.28% over the past one year. While a 52-week high of $99.50 was reached on 09/10/25, a 52-week low of $52.50 was recorded on 01/13/25.
Levels Of Support And Resistance For ANIP Stock
The 24-hour chart illustrates a support level at 80.71, which if violated will result in even more drops to 79.45. On the upside, there is a resistance level at 84.20. A further resistance level may holdings at 86.43.
How much short interest is there in ANI Pharmaceuticals Inc?
A steep rise in short interest was recorded in ANI Pharmaceuticals Inc stocks on 2025-10-31, growing by 0.17 million shares to a total of 2.5 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 2.33 million shares. There was a rise of 6.83%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 11, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $68 price target.
